Clozapine Tablet
Product Images NDC 51079-921

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 51079-921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clozapine Structural Formula (Image 01)

FDA Label Image

Figure 1. Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide In Patients With Schizophrenia Or Schizoaffective Disorder At High Risk Of Suicidality (Image 02)

FDA Label Image

Clozapine 25 mg Tablets Unit Carton Label (Image 03)

Clozapine Tablets, USP is a medication for which the dosage is not mentioned. It should be stored at approximately 2 to 3%. The rest of the text are unclear and have errors.*

FDA Label Image

Clozapine 100 mg Tablets Unit Carton Label (Image 04)

FDA Label Image

Unit Carton (Image 05)

This is a description of a medication called Clozapine in tablet form with a specific NDC number. The tablets are 100mg strength and the dosage should be determined by a healthcare professional. It includes a warning about the product and a reference to another medication called Soeatat®. Additionally, there is a reference to "Glaspne" but it is unclear what this is referring to. The last line includes the name "Mylan".*

FDA Label Image

Clozapine 200 mg Tablets Unit Carton Label (Image 06)

Description not-available. The text contains numerous errors and does not make any sense.*

FDA Label Image

Unit Carton (Image 07)

FDA Label Image

Unit Carton (Image 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.